DFTX

#1907
Definium Therapeutics, Inc. Common Shares
21.93 USD
-1.44%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
21.93
21.93
Intervallo Annuale
14.62
22.72
Variazione giornaliera
-1.44%
Variazione Mensile
+19.84%
Variazione di 6 mesi
+45.14%
Variazione Annuale
+45.14%
Chiusura Precedente
22.25
Apertura
21.93
Bid
Ask
Minimo
21.93
High
21.93
Volume
76
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 2.19 B
  • Employee 106
  • Founded 2010
  • CEO Robert Barrow
  • Website www.definiumtx.com
  • Headquarter British Columbia, Canada
  • FIGI BBG00F13HYQ7
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti

Definium Therapeutics Inc

Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.